Cargando…
Idiopathic multicentric Castleman disease with positive antiphospholipid antibody: atypical and undiagnosed autoimmune disease?
Idiopathic multicentric Castleman disease (iMCD) is a systemic disorder characterized by systemic inflammation and organ dysfunction associated with an increase in pro-inflammatory cytokines. Some patients with iMCD are positive for autoantibodies, although their significance and relationship with s...
Autores principales: | Nishimura, Yoshito, Nishikori, Asami, Sawada, Haruki, Czech, Torrey, Otsuka, Yuki, Nishimura, Midori Filiz, Mizuno, Hiroki, Sawa, Naoki, Momose, Shuji, Ohsawa, Kumiko, Otsuka, Fumio, Sato, Yasuharu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JSLRT
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9353850/ https://www.ncbi.nlm.nih.gov/pubmed/35249898 http://dx.doi.org/10.3960/jslrt.21038 |
Ejemplares similares
-
Idiopathic Plasmacytic Lymphadenopathy Forms an Independent Subtype of Idiopathic Multicentric Castleman Disease
por: Nishikori, Asami, et al.
Publicado: (2022) -
Historical and pathological overview of Castleman disease
por: Nishimura, Midori Filiz, et al.
Publicado: (2022) -
Clinical and Pathological Characteristics of Hyaline-Vascular Type Unicentric Castleman Disease: A 20-Year Retrospective Analysis
por: Nishimura, Midori Filiz, et al.
Publicado: (2021) -
Global public awareness of Castleman disease and TAFRO syndrome between 2015 and 2021: A Google Trends analysis
por: Nishimura, Yoshito, et al.
Publicado: (2022) -
Investigation of IgG4‐positive cells in idiopathic multicentric Castleman disease and validation of the 2020 exclusion criteria for IgG4‐related disease
por: Nishikori, Asami, et al.
Publicado: (2021)